Buprenorphine Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
The global Buprenorphine Hydrochloride market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Buprenorphine Hydrochloride market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
The global Buprenorphine Hydrochloride market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Buprenorphine Hydrochloride market segmented into
- Analgesic
- Capsule
- Analgesic
- Opioid Antagonist
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Siegfried
- Sanofi
- Johnson Matthey
- Mallinckrodt
- Noramco
- Unichemlabs
- Arevipharma
- Resonance-labs
- Sun Pharma
- Rusan Pharma
- Micro Orgo Chem
- Faranshimi
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BUPRENORPHINE HYDROCHLORIDE INDUSTRY
2.1 Summary about Buprenorphine Hydrochloride Industry
2.2 Buprenorphine Hydrochloride Market Trends
2.2.1 Buprenorphine Hydrochloride Production & Consumption Trends
2.2.2 Buprenorphine Hydrochloride Demand Structure Trends
2.3 Buprenorphine Hydrochloride Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tablet
4.2.2 Capsule
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Analgesic
4.3.2 Opioid Antagonist
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tablet
5.2.2 Capsule
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Analgesic
5.3.2 Opioid Antagonist
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tablet
6.2.2 Capsule
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Analgesic
6.3.2 Opioid Antagonist
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tablet
7.2.2 Capsule
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Analgesic
7.3.2 Opioid Antagonist
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tablet
8.2.2 Capsule
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Analgesic
8.3.2 Opioid Antagonist
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tablet
9.2.2 Capsule
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Analgesic
9.3.2 Opioid Antagonist
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Siegfried
10.1.2 Sanofi
10.1.3 Johnson Matthey
10.1.4 Mallinckrodt
10.1.5 Noramco
10.1.6 Unichemlabs
10.1.7 Arevipharma
10.1.8 Resonance-labs
10.1.9 Sun Pharma
10.1.10 Rusan Pharma
10.1.11 Micro Orgo Chem
10.1.12 Faranshimi
10.2 Buprenorphine Hydrochloride Sales Date of Major Players (2017-2020e)
10.2.1 Siegfried
10.2.2 Sanofi
10.2.3 Johnson Matthey
10.2.4 Mallinckrodt
10.2.5 Noramco
10.2.6 Unichemlabs
10.2.7 Arevipharma
10.2.8 Resonance-labs
10.2.9 Sun Pharma
10.2.10 Rusan Pharma
10.2.11 Micro Orgo Chem
10.2.12 Faranshimi
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BUPRENORPHINE HYDROCHLORIDE INDUSTRY
2.1 Summary about Buprenorphine Hydrochloride Industry
2.2 Buprenorphine Hydrochloride Market Trends
2.2.1 Buprenorphine Hydrochloride Production & Consumption Trends
2.2.2 Buprenorphine Hydrochloride Demand Structure Trends
2.3 Buprenorphine Hydrochloride Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tablet
4.2.2 Capsule
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Analgesic
4.3.2 Opioid Antagonist
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tablet
5.2.2 Capsule
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Analgesic
5.3.2 Opioid Antagonist
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tablet
6.2.2 Capsule
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Analgesic
6.3.2 Opioid Antagonist
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tablet
7.2.2 Capsule
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Analgesic
7.3.2 Opioid Antagonist
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tablet
8.2.2 Capsule
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Analgesic
8.3.2 Opioid Antagonist
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tablet
9.2.2 Capsule
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Analgesic
9.3.2 Opioid Antagonist
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Siegfried
10.1.2 Sanofi
10.1.3 Johnson Matthey
10.1.4 Mallinckrodt
10.1.5 Noramco
10.1.6 Unichemlabs
10.1.7 Arevipharma
10.1.8 Resonance-labs
10.1.9 Sun Pharma
10.1.10 Rusan Pharma
10.1.11 Micro Orgo Chem
10.1.12 Faranshimi
10.2 Buprenorphine Hydrochloride Sales Date of Major Players (2017-2020e)
10.2.1 Siegfried
10.2.2 Sanofi
10.2.3 Johnson Matthey
10.2.4 Mallinckrodt
10.2.5 Noramco
10.2.6 Unichemlabs
10.2.7 Arevipharma
10.2.8 Resonance-labs
10.2.9 Sun Pharma
10.2.10 Rusan Pharma
10.2.11 Micro Orgo Chem
10.2.12 Faranshimi
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Buprenorphine Hydrochloride Product Type Overview
2.Table Buprenorphine Hydrochloride Product Type Market Share List
3.Table Buprenorphine Hydrochloride Product Type of Major Players
4.Table Brief Introduction of Siegfried
5.Table Brief Introduction of Sanofi
6.Table Brief Introduction of Johnson Matthey
7.Table Brief Introduction of Mallinckrodt
8.Table Brief Introduction of Noramco
9.Table Brief Introduction of Unichemlabs
10.Table Brief Introduction of Arevipharma
11.Table Brief Introduction of Resonance-labs
12.Table Brief Introduction of Sun Pharma
13.Table Brief Introduction of Rusan Pharma
14.Table Brief Introduction of Micro Orgo Chem
15.Table Brief Introduction of Faranshimi
16.Table Products & Services of Siegfried
17.Table Products & Services of Sanofi
18.Table Products & Services of Johnson Matthey
19.Table Products & Services of Mallinckrodt
20.Table Products & Services of Noramco
21.Table Products & Services of Unichemlabs
22.Table Products & Services of Arevipharma
23.Table Products & Services of Resonance-labs
24.Table Products & Services of Sun Pharma
25.Table Products & Services of Rusan Pharma
26.Table Products & Services of Micro Orgo Chem
27.Table Products & Services of Faranshimi
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Buprenorphine Hydrochloride Product Type Overview
2.Table Buprenorphine Hydrochloride Product Type Market Share List
3.Table Buprenorphine Hydrochloride Product Type of Major Players
4.Table Brief Introduction of Siegfried
5.Table Brief Introduction of Sanofi
6.Table Brief Introduction of Johnson Matthey
7.Table Brief Introduction of Mallinckrodt
8.Table Brief Introduction of Noramco
9.Table Brief Introduction of Unichemlabs
10.Table Brief Introduction of Arevipharma
11.Table Brief Introduction of Resonance-labs
12.Table Brief Introduction of Sun Pharma
13.Table Brief Introduction of Rusan Pharma
14.Table Brief Introduction of Micro Orgo Chem
15.Table Brief Introduction of Faranshimi
16.Table Products & Services of Siegfried
17.Table Products & Services of Sanofi
18.Table Products & Services of Johnson Matthey
19.Table Products & Services of Mallinckrodt
20.Table Products & Services of Noramco
21.Table Products & Services of Unichemlabs
22.Table Products & Services of Arevipharma
23.Table Products & Services of Resonance-labs
24.Table Products & Services of Sun Pharma
25.Table Products & Services of Rusan Pharma
26.Table Products & Services of Micro Orgo Chem
27.Table Products & Services of Faranshimi
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Buprenorphine Hydrochloride Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Buprenorphine Hydrochloride Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Buprenorphine Hydrochloride Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Buprenorphine Hydrochloride Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Buprenorphine Hydrochloride Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Buprenorphine Hydrochloride Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Buprenorphine Hydrochloride Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Siegfried 2017-2020e
60.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Sanofi 2017-2020e
61.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Johnson Matthey 2017-2020e
62.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Mallinckrodt 2017-2020e
63.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Noramco 2017-2020e
64.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Unichemlabs 2017-2020e
65.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Arevipharma 2017-2020e
66.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Resonance-labs 2017-2020e
67.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Sun Pharma 2017-2020e
68.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Rusan Pharma 2017-2020e
69.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Micro Orgo Chem 2017-2020e
70.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Faranshimi 2017-2020e
71.
1.Figure Global Buprenorphine Hydrochloride Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Buprenorphine Hydrochloride Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Buprenorphine Hydrochloride Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Buprenorphine Hydrochloride Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Buprenorphine Hydrochloride Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Buprenorphine Hydrochloride Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Buprenorphine Hydrochloride Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Analgesic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Opioid Antagonist Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Siegfried 2017-2020e
60.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Sanofi 2017-2020e
61.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Johnson Matthey 2017-2020e
62.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Mallinckrodt 2017-2020e
63.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Noramco 2017-2020e
64.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Unichemlabs 2017-2020e
65.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Arevipharma 2017-2020e
66.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Resonance-labs 2017-2020e
67.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Sun Pharma 2017-2020e
68.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Rusan Pharma 2017-2020e
69.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Micro Orgo Chem 2017-2020e
70.Figure Buprenorphine Hydrochloride Sales Revenue (Million USD) of Faranshimi 2017-2020e
71.
